The six most-searched oral health symptoms associated with GLP-1 use tell the story clearly: Dry mouth / xerostomia Halitosis and bad breath Metallic taste in mouth Tooth sensitivity Every one of them is a direct downstream consequence of reduced saliva flow, and collectively they generated over 250,000 searches across the US in 2024
have not been reviewed by the FDA for safety, effectiveness, or quality
However, there is no established link between GLP-1 or GIP receptor agonists and thyroid cancer in humans, and the relevance of rodent C-cell findings to human thyroid physiology remains questionable due to species differences in C-cell distribution and GLP-1 receptor expression
It stimulates the pancreas to release insulin, which helps move glucose from the bloodstream into the bodys cells, providing them with energy
55 LudwigM.TodorovP.EgerodK.OlsonD.PersT
When to consider GLP-1 microdosing Based on current clinical practice patterns, practitioners are most commonly recommending GLP-1 microdosing in these scenarios: Partial responders: Patients on standard therapy who have improved but still experience breakthrough flares, residual inflammation, or persistent symptoms